Business Description
Ganga Pharmaceuticals Ltd
ISIN : INE615T01017
Total Employee Number:
17Compare
Compare
Traded in other countries / regions
539680.India IPO Date
2016-02-22Description
Ganga Pharmaceuticals Ltd is an India based producer of ayurvedic medicines. It is engaged in the business of manufacturing and trading in ayurvedic pharmaceuticals and allied products. The company is also involved in the marketing and distribution of bulk ayurvedic medicines. The firm offers ayurvedic medicines for acidity, anti-dandruff, anti-oxidants, dental care, diarrhea, iron tonic, liver disorder, weight management, kidney stone, joint pains, liver disorder and others.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | 1.54 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.33 | |||||
Beneish M-Score | -1.5 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -9.4 | |||||
3-Year EBITDA Growth Rate | 35.5 | |||||
3-Year EPS without NRI Growth Rate | 19.3 | |||||
3-Year FCF Growth Rate | -155.7 | |||||
3-Year Book Growth Rate | 1.6 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
9-Day RSI | 50.49 | |||||
14-Day RSI | 50.53 | |||||
6-1 Month Momentum % | -14.1 | |||||
12-1 Month Momentum % | -17.81 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.12 | |||||
Quick Ratio | 5.18 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 271.41 | |||||
Days Sales Outstanding | 124.51 | |||||
Days Payable | 43.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -13.3 | |||||
Shareholder Yield % | -12.84 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 44.41 | |||||
Operating Margin % | -1.87 | |||||
Net Margin % | 3.59 | |||||
EBITDA Margin % | 24.96 | |||||
FCF Margin % | -47.65 | |||||
OCF Margin % | -46.35 | |||||
ROE % | 1.28 | |||||
ROA % | 1.06 | |||||
ROIC % | -0.45 | |||||
3-Year ROIIC % | -1.67 | |||||
ROC (Joel Greenblatt) % | 4.85 | |||||
ROCE % | 2.78 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 70.59 | |||||
PE Ratio without NRI | 70.59 | |||||
Shiller PE Ratio | 47.59 | |||||
PEG Ratio | 2.8 | |||||
PS Ratio | 2.56 | |||||
PB Ratio | 0.85 | |||||
Price-to-Tangible-Book | 0.85 | |||||
EV-to-EBIT | 38.13 | |||||
EV-to-EBITDA | 12.22 | |||||
EV-to-Revenue | 3.05 | |||||
EV-to-FCF | -6.4 | |||||
Price-to-GF-Value | 1.01 | |||||
Price-to-Projected-FCF | 6.67 | |||||
Price-to-Median-PS-Value | 1.88 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.82 | |||||
Price-to-Graham-Number | 1.64 | |||||
| Price-to-Net-Current-Asset-Value | 1.14 | |||||
Earnings Yield (Greenblatt) % | 2.62 | |||||
FCF Yield % | -19 | |||||
Forward Rate of Return (Yacktman) % | 10.65 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ganga Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 28.279 | ||
| EPS (TTM) (₹) | 0.17 | ||
| Beta | 2.1225 | ||
| 3-Year Sharpe Ratio | 0.26 | ||
| 3-Year Sortino Ratio | 0.61 | ||
| Volatility % | 23.24 | ||
| 14-Day RSI | 50.53 | ||
| 14-Day ATR (₹) | 0.000032 | ||
| 20-Day SMA (₹) | 12 | ||
| 12-1 Month Momentum % | -17.81 | ||
| 52-Week Range (₹) | 9.35 - 14.6 | ||
| Shares Outstanding (Mil) | 5.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ganga Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ganga Pharmaceuticals Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ganga Pharmaceuticals Ltd Frequently Asked Questions
What is Ganga Pharmaceuticals Ltd(BOM:539680)'s stock price today?
The current price of BOM:539680 is ₹12.00. The 52 week high of BOM:539680 is ₹14.60 and 52 week low is ₹9.35.
When is next earnings date of Ganga Pharmaceuticals Ltd(BOM:539680)?
The next earnings date of Ganga Pharmaceuticals Ltd(BOM:539680) is .
Does Ganga Pharmaceuticals Ltd(BOM:539680) pay dividends? If so, how much?
Ganga Pharmaceuticals Ltd(BOM:539680) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Ganga Pharmaceuticals Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers